Review




Structured Review

Addgene inc app695
( A ) Schematic illustrating the sequential cleavage of <t>APP695</t> by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.
App695, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/app695/product/Addgene inc
Average 93 stars, based on 6 article reviews
app695 - by Bioz Stars, 2026-05
93/100 stars

Images

1) Product Images from "Membrane-associated periodic skeleton regulates major forms of endocytosis in neurons through a signaling-driven positive feedback loop"

Article Title: Membrane-associated periodic skeleton regulates major forms of endocytosis in neurons through a signaling-driven positive feedback loop

Journal: Science Advances

doi: 10.1126/sciadv.aeb0803

( A ) Schematic illustrating the sequential cleavage of APP695 by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.
Figure Legend Snippet: ( A ) Schematic illustrating the sequential cleavage of APP695 by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.

Techniques Used: Fluorescence, Activation Assay



Similar Products

86
Jackson Laboratory app695 swe ps1 de9 app ps1 double transgenic male mice
App695 Swe Ps1 De9 App Ps1 Double Transgenic Male Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/app695 swe ps1 de9 app ps1 double transgenic male mice/product/Jackson Laboratory
Average 86 stars, based on 1 article reviews
app695 swe ps1 de9 app ps1 double transgenic male mice - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

93
Addgene inc app695
( A ) Schematic illustrating the sequential cleavage of <t>APP695</t> by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.
App695, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/app695/product/Addgene inc
Average 93 stars, based on 1 article reviews
app695 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

93
Addgene inc pcax app695 swe ind vector
( A ) Schematic illustrating the sequential cleavage of <t>APP695</t> by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.
Pcax App695 Swe Ind Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcax app695 swe ind vector/product/Addgene inc
Average 93 stars, based on 1 article reviews
pcax app695 swe ind vector - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

90
Jackson Laboratory human app695 and human ps1 cdna
( A ) Schematic illustrating the sequential cleavage of <t>APP695</t> by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.
Human App695 And Human Ps1 Cdna, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human app695 and human ps1 cdna/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
human app695 and human ps1 cdna - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

85
Addgene inc app695 aenata
N2a cells transfected with <t>APP695</t> and LAMP1-mCh (red) and incubated with fluorescently-tagged A) N-terminal anti-APP (APP), B) Aβ-region targeting 6E10 antibodies, or C) anti-NCAM antibodies (green) on ice for 20 minutes, then immediately fixed or allowed to incubate at 37°C for 15 minutes. Colocalization was assessed between crosslinked APP and LAMP1 (white pixels). D) Quantification of the mean % of APP colocalized with LAMP1 from three replicate experiments (n=3; 10 images per replicate), with significance calculated by a one-way ANOVA with Tukey’s test. E) N2a cells transfected with APP695 and LAMP1-mCh (red) that were treated with DMSO, 20μM Pitstop2 or 10μM EIPA. APP was then bound/crosslinked by antibody and imaged after 15 minutes. Colocalization was assessed between crosslinked APP and LAMP1 (white pixels). F) Quantification of the mean % of APP colocalized with LAMP1 (n=3; 10 images per replicate), with significance calculated by a one-way ANOVA with Tukey’s test. Data is presented as mean ± SEM. * p<0.05; Scale bar = 5μm .
App695 Aenata, supplied by Addgene inc, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/app695 aenata/product/Addgene inc
Average 85 stars, based on 1 article reviews
app695 aenata - by Bioz Stars, 2026-05
85/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic illustrating the sequential cleavage of APP695 by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.

Journal: Science Advances

Article Title: Membrane-associated periodic skeleton regulates major forms of endocytosis in neurons through a signaling-driven positive feedback loop

doi: 10.1126/sciadv.aeb0803

Figure Lengend Snippet: ( A ) Schematic illustrating the sequential cleavage of APP695 by β-secretase and γ-secretase to produce Aβ42. ( B ) Schematic illustrating the structure of SEP-APP. ( C ) Left: Epi-fluorescence images of pERK in neurons overexpressing SEP-APP without ligand treatment. Middle: The same as the left but treated with GFP nanobody. Right: The same as the middle but with dyngo-4a preincubation before GFP nanobody treatment. Scale bars, 25 μm. ( D ) Time course of ERK activation in neurons under the same conditions as in (C). ( E ) 3D STORM images of immunostained βIII-spectrin in dendrites of neurons pretreated with DMSO, dyngo-4a, U0126, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 1 μm. ( F ) Averaged 1D autocorrelation amplitude of βIII-spectrin, calculated for the same conditions as in (E). ( G ) Confocal fluorescence images of CTB (magenta) and internalized SEP-APP (green) in neurons pretreated with DMSO, MDL, or VAD followed by GFP nanobody treatment. Scale bars, 10 μm. ( H ) Boxplots of SEP-APP endosome area fractions. ( I ) Left: Confocal fluorescence images of MAP2 (magenta) and intracellular Aβ42 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 10 μm. ( J ) Boxplots of intracellular Aβ42 area fractions in somatodendritic regions of neurons. ( K ) Left, SIM images of MAP2 (magenta) and cleaved caspase-3 (green) in WT neurons, neurons overexpressing APPwt, and neurons overexpressing APPswe. Right: The same as the left but in βII-spectrin KD neurons. Scale bars, 2 μm. ( L ) Boxplots of cleaved caspase-3 area fractions in dendrites of neurons. ( M ) Schematic illustrating APP endocytosis triggers downstream ERK signaling, leading to MPS degradation through caspase- and calpain-mediated spectrin cleavage. This degradation further accelerates APP endocytosis, promoting intracellular Aβ42 accumulation and caspase-3 activation.

Article Snippet: Coding sequences for CAV1, FLOT1, SH3GL1 (synthesized by Twist Bioscience), APP695 (Addgene, plasmid #114193), and Basp1 (GenoCopoeia, plasmid # EX-Mm10271-M98) were fused to a C-terminal GFP via a flexible polypeptide linker and cloned into the FUGW vector, generating GFP-tagged constructs for Cav1, Flot1, EndoA2, APPwt, and Basp1.

Techniques: Fluorescence, Activation Assay

N2a cells transfected with APP695 and LAMP1-mCh (red) and incubated with fluorescently-tagged A) N-terminal anti-APP (APP), B) Aβ-region targeting 6E10 antibodies, or C) anti-NCAM antibodies (green) on ice for 20 minutes, then immediately fixed or allowed to incubate at 37°C for 15 minutes. Colocalization was assessed between crosslinked APP and LAMP1 (white pixels). D) Quantification of the mean % of APP colocalized with LAMP1 from three replicate experiments (n=3; 10 images per replicate), with significance calculated by a one-way ANOVA with Tukey’s test. E) N2a cells transfected with APP695 and LAMP1-mCh (red) that were treated with DMSO, 20μM Pitstop2 or 10μM EIPA. APP was then bound/crosslinked by antibody and imaged after 15 minutes. Colocalization was assessed between crosslinked APP and LAMP1 (white pixels). F) Quantification of the mean % of APP colocalized with LAMP1 (n=3; 10 images per replicate), with significance calculated by a one-way ANOVA with Tukey’s test. Data is presented as mean ± SEM. * p<0.05; Scale bar = 5μm .

Journal: bioRxiv

Article Title: Macropinocytosis of amyloid precursor protein requires the adaptor protein Fe65 and the recruitment and activity of Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA

doi: 10.1101/2025.03.02.641070

Figure Lengend Snippet: N2a cells transfected with APP695 and LAMP1-mCh (red) and incubated with fluorescently-tagged A) N-terminal anti-APP (APP), B) Aβ-region targeting 6E10 antibodies, or C) anti-NCAM antibodies (green) on ice for 20 minutes, then immediately fixed or allowed to incubate at 37°C for 15 minutes. Colocalization was assessed between crosslinked APP and LAMP1 (white pixels). D) Quantification of the mean % of APP colocalized with LAMP1 from three replicate experiments (n=3; 10 images per replicate), with significance calculated by a one-way ANOVA with Tukey’s test. E) N2a cells transfected with APP695 and LAMP1-mCh (red) that were treated with DMSO, 20μM Pitstop2 or 10μM EIPA. APP was then bound/crosslinked by antibody and imaged after 15 minutes. Colocalization was assessed between crosslinked APP and LAMP1 (white pixels). F) Quantification of the mean % of APP colocalized with LAMP1 (n=3; 10 images per replicate), with significance calculated by a one-way ANOVA with Tukey’s test. Data is presented as mean ± SEM. * p<0.05; Scale bar = 5μm .

Article Snippet: APP695-AENATA (pCAX-APP-AENATA) was a gift from Dennis Selkoe and Tracy Young-Pearse (Addgene plasmid #30144).

Techniques: Transfection, Incubation

A) N2a cells transfected with Fe65-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were incubated with fluorescent anti-APP or anti-NCAM antibodies (red) on ice, then immediately fixed on ice as a baseline (00:00) or incubated for 30 seconds (00:30), 2 minutes (02:00), 5 minutes (5:00), and 10 minutes (10:00). Colocalization between signals is indicated by white pixels. B/C) Quantification of colocalization data (n=3; 15 images per replicate) is represented as the difference between the colocalization at each timepoint to the colocalization at baseline (mean % colocalized at XX:XX – mean % colocalized at 00:00). * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. D) N2a cells transfected with Arf6-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Experiment above was repeated with Arf6-EGFP expressing cells. Colocalization between signals is indicated by white pixels. E/F) Quantification of colocalization data (n=3; 15 images per replicate). Data representation and analysis from G/H) was repeated for N2a cells expressing Arf6-GFP. * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. Significance was measured by a two-way ANOVA with a Tukey’s test using a single pooled variance. Data is presented as mean ± SEM. */# p<0.05; Scale bar = 5μm .

Journal: bioRxiv

Article Title: Macropinocytosis of amyloid precursor protein requires the adaptor protein Fe65 and the recruitment and activity of Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA

doi: 10.1101/2025.03.02.641070

Figure Lengend Snippet: A) N2a cells transfected with Fe65-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were incubated with fluorescent anti-APP or anti-NCAM antibodies (red) on ice, then immediately fixed on ice as a baseline (00:00) or incubated for 30 seconds (00:30), 2 minutes (02:00), 5 minutes (5:00), and 10 minutes (10:00). Colocalization between signals is indicated by white pixels. B/C) Quantification of colocalization data (n=3; 15 images per replicate) is represented as the difference between the colocalization at each timepoint to the colocalization at baseline (mean % colocalized at XX:XX – mean % colocalized at 00:00). * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. D) N2a cells transfected with Arf6-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Experiment above was repeated with Arf6-EGFP expressing cells. Colocalization between signals is indicated by white pixels. E/F) Quantification of colocalization data (n=3; 15 images per replicate). Data representation and analysis from G/H) was repeated for N2a cells expressing Arf6-GFP. * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. Significance was measured by a two-way ANOVA with a Tukey’s test using a single pooled variance. Data is presented as mean ± SEM. */# p<0.05; Scale bar = 5μm .

Article Snippet: APP695-AENATA (pCAX-APP-AENATA) was a gift from Dennis Selkoe and Tracy Young-Pearse (Addgene plasmid #30144).

Techniques: Transfection, Incubation, Expressing

A) N2a cells transfected with Rac1-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were incubated with tagged anti-APP or anti-NCAM antibodies (red) on ice and then were either immediately fixed on ice as a baseline (00:00), or incubated for 30 seconds (00:30), 2 minutes (02:00), 5 minutes (5:00), and 10 minutes (10:00) at 37°C 5% CO2 prior to fixation. Colocalization between signals is indicated by white pixels. B/C) Quantification of colocalization data (n=3; 15 images per replicate) is represented as the difference between the colocalization at each timepoint to the colocalization at baseline (mean % colocalized at XX:XX – mean % colocalized at 00:00). * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. D) N2a cells transfected with Cdc42-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Experiment from A) was repeated with Cdc42-EGFP expressing cells. Colocalization between signals is indicated by white pixels. E/F) Quantification of colocalization data (n=3; 15 images per replicate). Data representation and analysis from B/C) was repeated for N2a cells expressing Cdc42-EGFP. * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. G) N2a cells transfected with RhoA-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Experiment from A) was repeated with RhoA-EGFP expressing cells. Colocalization between signals is indicated by white pixels. H/I) Quantification of colocalization data (n=3; 15 images per replicate). Data representation and analysis from B/C) was repeated for N2a cells expressing RhoA-EGFP. * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. Significance was measured by a two-way ANOVA with a Tukey’s test using a single pooled variance. Data is presented as mean ± SEM. */# p<0.05; Scale bar = 5μm .

Journal: bioRxiv

Article Title: Macropinocytosis of amyloid precursor protein requires the adaptor protein Fe65 and the recruitment and activity of Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA

doi: 10.1101/2025.03.02.641070

Figure Lengend Snippet: A) N2a cells transfected with Rac1-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were incubated with tagged anti-APP or anti-NCAM antibodies (red) on ice and then were either immediately fixed on ice as a baseline (00:00), or incubated for 30 seconds (00:30), 2 minutes (02:00), 5 minutes (5:00), and 10 minutes (10:00) at 37°C 5% CO2 prior to fixation. Colocalization between signals is indicated by white pixels. B/C) Quantification of colocalization data (n=3; 15 images per replicate) is represented as the difference between the colocalization at each timepoint to the colocalization at baseline (mean % colocalized at XX:XX – mean % colocalized at 00:00). * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. D) N2a cells transfected with Cdc42-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Experiment from A) was repeated with Cdc42-EGFP expressing cells. Colocalization between signals is indicated by white pixels. E/F) Quantification of colocalization data (n=3; 15 images per replicate). Data representation and analysis from B/C) was repeated for N2a cells expressing Cdc42-EGFP. * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. G) N2a cells transfected with RhoA-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Experiment from A) was repeated with RhoA-EGFP expressing cells. Colocalization between signals is indicated by white pixels. H/I) Quantification of colocalization data (n=3; 15 images per replicate). Data representation and analysis from B/C) was repeated for N2a cells expressing RhoA-EGFP. * denotes significant difference to baseline within condition; # denotes significant difference between groups at the indicated timepoint. Significance was measured by a two-way ANOVA with a Tukey’s test using a single pooled variance. Data is presented as mean ± SEM. */# p<0.05; Scale bar = 5μm .

Article Snippet: APP695-AENATA (pCAX-APP-AENATA) was a gift from Dennis Selkoe and Tracy Young-Pearse (Addgene plasmid #30144).

Techniques: Transfection, Incubation, Expressing

A) N2a cells transfected with Fe65-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated with 0.1% DMSO, 5μM NAV-2729, 10μM EHT 1864, 10μM ML 141, and 35μM Rhosin. After treatment, cells were incubated with tagged anti-APP antibodies (red) on ice and then fixed following an incubation for 30 seconds. Colocalization was assessed between Fe65 and antibody bound/crosslinked APP or PLC8PH (white pixels). B) Quantification of the mean % of Fe65 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). C) N2a cells transfected with Arf6-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated with 0.1% DMSO, 5μM NAV-2729, 10μM EHT 1864, 10μM ML 141, and 35μM Rhosin. After treatment, cells were incubated with tagged anti-APP antibodies (red) on ice and then fixed following a 30 second incubation. Colocalization was assessed between Arf6 and bound/crosslinked APP or PLC8PH (white pixels). D) Quantification of the mean % of Arf6 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). Significant changes in the percentage colocalized between treatments were assessed by a one-way ANOVA with Tukey’s test . Data is presented as mean ± SEM. *p<0.05; Scale bar = 5μm .

Journal: bioRxiv

Article Title: Macropinocytosis of amyloid precursor protein requires the adaptor protein Fe65 and the recruitment and activity of Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA

doi: 10.1101/2025.03.02.641070

Figure Lengend Snippet: A) N2a cells transfected with Fe65-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated with 0.1% DMSO, 5μM NAV-2729, 10μM EHT 1864, 10μM ML 141, and 35μM Rhosin. After treatment, cells were incubated with tagged anti-APP antibodies (red) on ice and then fixed following an incubation for 30 seconds. Colocalization was assessed between Fe65 and antibody bound/crosslinked APP or PLC8PH (white pixels). B) Quantification of the mean % of Fe65 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). C) N2a cells transfected with Arf6-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated with 0.1% DMSO, 5μM NAV-2729, 10μM EHT 1864, 10μM ML 141, and 35μM Rhosin. After treatment, cells were incubated with tagged anti-APP antibodies (red) on ice and then fixed following a 30 second incubation. Colocalization was assessed between Arf6 and bound/crosslinked APP or PLC8PH (white pixels). D) Quantification of the mean % of Arf6 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). Significant changes in the percentage colocalized between treatments were assessed by a one-way ANOVA with Tukey’s test . Data is presented as mean ± SEM. *p<0.05; Scale bar = 5μm .

Article Snippet: APP695-AENATA (pCAX-APP-AENATA) was a gift from Dennis Selkoe and Tracy Young-Pearse (Addgene plasmid #30144).

Techniques: Transfection, Incubation

A) N2a cells transfected with Rac1-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated with 0.1% DMSO, 5μM NAV-2729, 10μM EHT 1864, 10μM ML 141, and 35μM Rhosin. After treatment, cells were incubated with tagged anti-APP antibodies (red) on ice and then fixed following a 30 second incubation. Colocalization was assessed between Rac1 and bound/crosslinked APP or PLC8PH (white pixels). B) Quantification of the mean % of Rac1 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). C) N2a cells transfected with Cdc42-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated as described in A), then incubated with tagged anti-APP antibodies (red) on ice and fixed following a 30 second incubation. Colocalization was assessed between Cdc42 and bound/crosslinked APP or PLC8PH (white pixels). D) Quantification of the mean % of Cdc42 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). E) N2a cells transfected with RhoA-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated as described in A), then incubated with tagged anti-APP antibodies (red) on ice and then fixed following an incubation for 30 seconds. Colocalization was assessed between RhoA and bound/crosslinked APP or PLC8PH (white pixels). F) Quantification of the mean % of RhoA colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). Significant changes in the percentage colocalized between treatments were assessed by a one-way ANOVA with Tukey’s test . Data is presented as mean ± SEM. *p<0.05; Scale bar = 5μm .

Journal: bioRxiv

Article Title: Macropinocytosis of amyloid precursor protein requires the adaptor protein Fe65 and the recruitment and activity of Arf6 and the RhoGTPases Rac1, Cdc42 and RhoA

doi: 10.1101/2025.03.02.641070

Figure Lengend Snippet: A) N2a cells transfected with Rac1-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated with 0.1% DMSO, 5μM NAV-2729, 10μM EHT 1864, 10μM ML 141, and 35μM Rhosin. After treatment, cells were incubated with tagged anti-APP antibodies (red) on ice and then fixed following a 30 second incubation. Colocalization was assessed between Rac1 and bound/crosslinked APP or PLC8PH (white pixels). B) Quantification of the mean % of Rac1 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). C) N2a cells transfected with Cdc42-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated as described in A), then incubated with tagged anti-APP antibodies (red) on ice and fixed following a 30 second incubation. Colocalization was assessed between Cdc42 and bound/crosslinked APP or PLC8PH (white pixels). D) Quantification of the mean % of Cdc42 colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). E) N2a cells transfected with RhoA-EGFP (green), PLC8PH-mRFP (magenta) and APP695. Cells were treated as described in A), then incubated with tagged anti-APP antibodies (red) on ice and then fixed following an incubation for 30 seconds. Colocalization was assessed between RhoA and bound/crosslinked APP or PLC8PH (white pixels). F) Quantification of the mean % of RhoA colocalized with APP (left) or PLC8PH (right) from three replicate experiments (n=3; 15 images per replicate). Significant changes in the percentage colocalized between treatments were assessed by a one-way ANOVA with Tukey’s test . Data is presented as mean ± SEM. *p<0.05; Scale bar = 5μm .

Article Snippet: APP695-AENATA (pCAX-APP-AENATA) was a gift from Dennis Selkoe and Tracy Young-Pearse (Addgene plasmid #30144).

Techniques: Transfection, Incubation